@article{lemaitre_410p_2023,
	series = {Abstract {Book} of the {ESMO} {Congress} 2023, 20 - 24 {October} 2023.},
	title = {{410P} {Patients} treated with pertuzumab followed by {T}-{DM1} for breast cancer in {France} from 2014 to 2021: {A} survival analysis of 10,408 patients from the {French} {National} {Hospital} discharge summary database ({PMSI})},
	volume = {34},
	issn = {0923-7534},
	shorttitle = {{410P} {Patients} treated with pertuzumab followed by {T}-{DM1} for breast cancer in {France} from 2014 to 2021},
	url = {https://www.sciencedirect.com/science/article/pii/S0923753423014230},
	doi = {10.1016/j.annonc.2023.09.587},
	urldate = {2024-06-07},
	journal = {Annals of Oncology},
	author = {Lemaitre, J. and Chazard, E. and Cren, P-Y. and Lebellec, L. and Penel, N. and Cheymol, C.},
	month = oct,
	year = {2023},
	pages = {S355},
}

{"_id":"sLi7Xm3i7oYmkdEiZ","bibbaseid":"lemaitre-chazard-cren-lebellec-penel-cheymol-410ppatientstreatedwithpertuzumabfollowedbytdm1forbreastcancerinfrancefrom2014to2021asurvivalanalysisof10408patientsfromthefrenchnationalhospitaldischargesummarydatabasepmsi-2023","author_short":["Lemaitre, J.","Chazard, E.","Cren, P.","Lebellec, L.","Penel, N.","Cheymol, C."],"bibdata":{"bibtype":"article","type":"article","series":"Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.","title":"410P Patients treated with pertuzumab followed by T-DM1 for breast cancer in France from 2014 to 2021: A survival analysis of 10,408 patients from the French National Hospital discharge summary database (PMSI)","volume":"34","issn":"0923-7534","shorttitle":"410P Patients treated with pertuzumab followed by T-DM1 for breast cancer in France from 2014 to 2021","url":"https://www.sciencedirect.com/science/article/pii/S0923753423014230","doi":"10.1016/j.annonc.2023.09.587","urldate":"2024-06-07","journal":"Annals of Oncology","author":[{"propositions":[],"lastnames":["Lemaitre"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Chazard"],"firstnames":["E."],"suffixes":[]},{"propositions":[],"lastnames":["Cren"],"firstnames":["P-Y."],"suffixes":[]},{"propositions":[],"lastnames":["Lebellec"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Penel"],"firstnames":["N."],"suffixes":[]},{"propositions":[],"lastnames":["Cheymol"],"firstnames":["C."],"suffixes":[]}],"month":"October","year":"2023","pages":"S355","bibtex":"@article{lemaitre_410p_2023,\n\tseries = {Abstract {Book} of the {ESMO} {Congress} 2023, 20 - 24 {October} 2023.},\n\ttitle = {{410P} {Patients} treated with pertuzumab followed by {T}-{DM1} for breast cancer in {France} from 2014 to 2021: {A} survival analysis of 10,408 patients from the {French} {National} {Hospital} discharge summary database ({PMSI})},\n\tvolume = {34},\n\tissn = {0923-7534},\n\tshorttitle = {{410P} {Patients} treated with pertuzumab followed by {T}-{DM1} for breast cancer in {France} from 2014 to 2021},\n\turl = {https://www.sciencedirect.com/science/article/pii/S0923753423014230},\n\tdoi = {10.1016/j.annonc.2023.09.587},\n\turldate = {2024-06-07},\n\tjournal = {Annals of Oncology},\n\tauthor = {Lemaitre, J. and Chazard, E. and Cren, P-Y. and Lebellec, L. and Penel, N. and Cheymol, C.},\n\tmonth = oct,\n\tyear = {2023},\n\tpages = {S355},\n}\n\n","author_short":["Lemaitre, J.","Chazard, E.","Cren, P.","Lebellec, L.","Penel, N.","Cheymol, C."],"key":"lemaitre_410p_2023","id":"lemaitre_410p_2023","bibbaseid":"lemaitre-chazard-cren-lebellec-penel-cheymol-410ppatientstreatedwithpertuzumabfollowedbytdm1forbreastcancerinfrancefrom2014to2021asurvivalanalysisof10408patientsfromthefrenchnationalhospitaldischargesummarydatabasepmsi-2023","role":"author","urls":{"Paper":"https://www.sciencedirect.com/science/article/pii/S0923753423014230"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/1597782/collections/MSB7W4UM/items?key=gxIPM4PJtMVcB8OpssCWodtP&format=bibtex&limit=100&start=0&sort=date","dataSources":["doevpoZ8x7wJceFTM"],"keywords":[],"search_terms":["410p","patients","treated","pertuzumab","followed","dm1","breast","cancer","france","2014","2021","survival","analysis","408","patients","french","national","hospital","discharge","summary","database","pmsi","lemaitre","chazard","cren","lebellec","penel","cheymol"],"title":"410P Patients treated with pertuzumab followed by T-DM1 for breast cancer in France from 2014 to 2021: A survival analysis of 10,408 patients from the French National Hospital discharge summary database (PMSI)","year":2023}